Phase
Condition
Amyotrophic Lateral Sclerosis (Als)
Scar Tissue
Myasthenia Gravis (Chronic Weakness)
Treatment
Quadriceps Combined Test
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
A male or female patient of legal age with suspected ALS (bulbar or spinal) whomeets the criteria for "possible", "probable" or "definite" ALS according to theAwaji criteria
Able to give informed consent to participate in the research
Enrolled in a Social Security plan
Exclusion
Exclusion Criteria:
Pregnant or breastfeeding woman
Severe progressive pathology other than ALS.
Comorbidities with another neurological disease altering motor skills.
Contraindication to trans-cranial magnetic stimulation: epilepsy, pacemaker,intracranial ferromagnetic foreign body (clip, aneurysm, implants)...
Chronic alcoholism
Cognitive disorders or major incapacity making it impossible to understand the studyand sign an informed consent (fronto-temporal dementia, psychiatric conditions ofpsychotic type, language disorders)
Refusal to participate.
Patients under legal protection (guardianship, curators, safeguard of justice)
Study Design
Connect with a study center
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.